117 results
Keyword Didanosine Remove keyword
-
List item
Referral: Didanosine
didanosine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/09/2013, EC decision date: 20/11/2013, Last updated: 10/12/2013Didanosine … authorisation of the medicine Didanosine. The Agency's Committee for … concluded that the benefits of Didanosine outweigh its risks, and the … -
List item
Press release: Updated advice on body fat changes and lactic acidosis with HIV medicines
CHMP, Last updated: 23/10/2015stavudine and, probably, didanosine), and that these fat changes … zidovudine, stavudine, and didanosine. … stavudine and, probably, didanosine), and that these fat changes … -
List item
Human medicine European public assessment report (EPAR): Epivir
lamivudine, HIV Infections
Date of authorisation: 08/08/1996, Revision: 46, Authorised, Last updated: 29/03/2021taken with zidovudine to didanosine (another antiviral medicine … taken with zidovudine to didanosine (another antiviral medicine … -
List item
Human medicine European public assessment report (EPAR): Emtriva
emtricitabine, HIV Infections
Date of authorisation: 24/10/2003, Revision: 30, Authorised, Last updated: 23/07/2020Emtriva (in combination with didanosine and efavirenz) had viral … Emtriva (in combination with didanosine and efavirenz) had viral … -
List item
Press release: Further data needed to determine risk of heart attack with abacavir
Last updated: 02/04/2008association was seen with the NRTI didanosine. In a pooled analysis of 54 … Ziagen , Kivexa and Trivizir . Didanosine is an NRTI also indicated … association was seen with the NRTI didanosine. In a pooled analysis of … -
List item
Human medicine European public assessment report (EPAR): Viramune
nevirapine, HIV Infections
Date of authorisation: 04/02/1998, Revision: 39, Authorised, Last updated: 18/11/2020combination with zidovudine and didanosine (other antiviral medicines … combination with zidovudine and didanosine (other antiviral medicines … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2013
CHMP, Last updated: 20/09/2013Didanosine … -
List item
Human medicine European public assessment report (EPAR): Viread
tenofovir disoproxil fumarate, Hepatitis B, Chronic, HIV Infections
Date of authorisation: 04/02/2002, Revision: 55, Authorised, Last updated: 25/01/2021fumarate (TDF, Viread) and didanosine (ddI, Videx) PDF icon application/pdf … fumarate (TDF, Viread1) and didanosine (ddI, Videx2) EMEA/62331/2005 … fumarate (TDF, Viread1) and didanosine (ddI, Videx2) The European … -
List item
National expert: Pere Domingo, Spanish Agency of Medicines and Medical Devices (updated)
- Declaration of interests - 82.62 KB | PDF
- Curriculum Vitae - 122.38 KB | PDF
-
List item
Press release: European Medicines Agency welcomes continuation of D:A:D study
Last updated: 03/02/2009recent use of abacavir and didanosine was found and is being further … recent use of abacavir and didanosine was found and is being further … -
List item
News: Public Statement on the risk of drug interactions with Hypericum perforatum (St John's Wort) and antiretroviral medicinal products
Last updated: 28/02/2000products containing zidovudine, didanosine and zalcitabine. Until more … medicinal products containing zidovudine, didanosine and zalcitabine. 1 The Lancet … -
List item
Human medicine European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan (updated)
emtricitabine, tenofovir disoproxil maleate, HIV Infections
Date of authorisation: 16/12/2016,
, Revision: 8, Authorised, Last updated: 29/04/2021
-
List item
Human medicine European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Krka d.d. (updated)
emtricitabine, tenofovir disoproxil succinate, HIV Infections
Date of authorisation: 28/04/2017,, Revision: 8, Authorised, Last updated: 22/04/2021
-
List item
Human medicine European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Zentiva (updated)
emtricitabine, tenofovir disoproxil phosphate, HIV Infections
Date of authorisation: 09/11/2016,, Revision: 5, Authorised, Last updated: 22/04/2021
-
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Krka (updated)
efavirenz, emtricitabine, tenofovir disoproxil succinate, HIV Infections
Date of authorisation: 08/02/2018,, Revision: 6, Authorised, Last updated: 08/04/2021
-
List item
Human medicine European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Krka (updated)
emtricitabine, tenofovir disoproxil succinate, HIV Infections
Date of authorisation: 09/12/2016,, Revision: 9, Authorised, Last updated: 09/04/2021
-
List item
Human medicine European public assessment report (EPAR): Tenofovir disoproxil Zentiva (updated)
tenofovir disoproxil phosphate, HIV Infections
Date of authorisation: 15/09/2016,, Revision: 9, Authorised, Last updated: 14/04/2021
-
List item
Human medicine European public assessment report (EPAR): Xromi (updated)
hydroxycarbamide, Anemia, Sickle Cell
Date of authorisation: 01/07/2019, Authorised, Last updated: 08/04/2021 -
List item
Human medicine European public assessment report (EPAR): Truvada
emtricitabine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 20/02/2005, Revision: 44, Authorised, Last updated: 31/03/2021 -
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan
efavirenz, emtricitabine, tenofovir disoproxil maleate, HIV Infections
Date of authorisation: 05/09/2017,, Revision: 9, Authorised, Last updated: 18/03/2021
-
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva
efavirenz, emtricitabine, tenofovir disoproxil phosphate, HIV Infections
Date of authorisation: 17/07/2017,, Revision: 6, Authorised, Last updated: 22/02/2021
-
List item
Human medicine European public assessment report (EPAR): Combivir
lamivudine, zidovudine, HIV Infections
Date of authorisation: 18/03/1998, Revision: 32, Authorised, Last updated: 25/03/2021 -
List item
Human medicine European public assessment report (EPAR): Trizivir
abacavir (as sulfate), lamivudine, zidovudine, HIV Infections
Date of authorisation: 27/12/2000, Revision: 36, Authorised, Last updated: 05/03/2021 -
List item
Human medicine European public assessment report (EPAR): Ziagen
abacavir, HIV Infections
Date of authorisation: 08/07/1999, Revision: 43, Authorised, Last updated: 24/03/2021 -
List item
Human medicine European public assessment report (EPAR): Kivexa
abacavir, lamivudine, HIV Infections
Date of authorisation: 16/12/2004, Revision: 33, Authorised, Last updated: 25/02/2021